Chris Degnan Uro Gen Pharma Ltd. (URGN) insider trading activity

URGN Quotes by TradingView

Chris Degnan is Chief Financial Officer of UroGen Pharma Ltd.. Currently has a direct ownership of 2,280 shares of URGN, which is worth approximately $55,472. The most recent transaction as insider was on Oct 08, 2025, when has been sold 2,203 shares (Ordinary Shares) at a price of $16.85 per share, resulting in proceeds of $37,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.28K
n/a 3M change
n/a 12M change
Total Value Held $55,472

Chris Degnan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 08 2025
SELL
Open market or private sale
$37,120 $16.85 p/Share
2,203 Reduced 49.14%
2,280 Ordinary Shares
Oct 08 2025
BUY
Exercise of conversion of derivative security
-
4,483 Added 50.0%
4,483 Ordinary Shares

Also insider at

GRTX
Galera Therapeutics, Inc. Healthcare
Chief Financial Officer
CD

Chris Degnan

Chief Financial Officer
Malvern, PA

Track Institutional and Insider Activities on URGN

Follow UroGen Pharma Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells URGN shares.

Notify only if

Insider Trading

Get notified when an Uro Gen Pharma Ltd. insider buys or sells URGN shares.

Notify only if

News

Receive news related to UroGen Pharma Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on URGN